AMRX - Amneal Pharmaceuticals Inc

13.24
-0.020   -0.151%

Share volume: 1,550,712
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$13.26
-0.02
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
52%
Profitability 53%
Dept financing 43%
Liquidity 59%
Performance 51%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.85%
1 Month
-8.82%
3 Months
11.54%
6 Months
36.07%
1 Year
48.76%
2 Year
149.34%
Key data
Stock price
$13.24
P/E Ratio 
N/A
DAY RANGE
$12.90 - $13.28
EPS 
$0.23
52 WEEK RANGE
$6.68 - $15.42
52 WEEK CHANGE
$52.18
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
314.629 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-05-2025
BETA 
0.91
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,369,446
AVERAGE 30 VOLUME 
$2,003,034
Company detail
CEO: Chintu Patel
Region: US
Website: amneal.com
Employees: 7,600
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products. The company operates through three segments: Generics, Specialty, and AvKARE. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies.

Recent news